We are live on ! Find out more
GT

Greenleaf Trust Portfolio holdings

AUM $10.4B
1-Year Est. Return 0.97%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$2.66B
AUM Growth
+$111M
Cap. Flow
-$21.3M
Cap. Flow %
-0.8%
Top 10 Hldgs %
84.77%
Holding
167
New
3
Increased
48
Reduced
73
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 79.83%
2 Technology 3.85%
3 Financials 2.4%
4 Energy 1.58%
5 Industrials 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
76
BorgWarner
BWA
$12.8B
$992K 0.04%
22,220
+238
+1% +$10K
AMGN icon
77
Amgen
AMGN
$209B
$978K 0.04%
8,736
-288
-3% -$31.2K
V icon
78
Visa
V
$677B
$952K 0.04%
19,924
-976
-5% -$45.1K
SSYS icon
79
Stratasys
SSYS
$666M
$942K 0.04%
9,300
SLB icon
80
SLB Ltd
SLB
$72.7B
$941K 0.04%
10,647
-1,630
-13% -$134K
VIAV icon
81
Viavi Solutions
VIAV
$7.95B
$897K 0.03%
107,238
PM icon
82
Philip Morris
PM
$309B
$861K 0.03%
9,941
+929
+10% +$81.2K
MCHP icon
83
Microchip Technology
MCHP
$38.8B
$856K 0.03%
42,508
+208
+0.5% +$4.12K
NUAN
84
DELISTED
Nuance Communications, Inc.
NUAN
$840K 0.03%
51,940
+5,584
+12% +$92.4K
AMZN icon
85
Amazon
AMZN
$2.44T
$808K 0.03%
51,680
+1,660
+3% +$24.7K
MSFT icon
86
Microsoft
MSFT
$2.9T
$803K 0.03%
24,119
-825
-3% -$27.1K
EMR icon
87
Emerson Electric
EMR
$81.6B
$768K 0.03%
11,866
-510
-4% -$31.2K
FVD icon
88
First Trust Value Line Dividend Fund
FVD
$8.44B
$768K 0.03%
38,320
-7,144
-16% -$144K
MRK icon
89
Merck
MRK
$322B
$764K 0.03%
16,818
+1,788
+12% +$81.6K
GSK icon
90
GSK
GSK
$107B
$748K 0.03%
11,930
-988
-8% -$63.6K
BMY icon
91
Bristol-Myers Squibb
BMY
$129B
$708K 0.03%
15,307
-395
-3% -$17.3K
MKC icon
92
McCormick & Company Non-Voting
MKC
$14B
$706K 0.03%
21,814
-200
-0.9% -$7.01K
LAMR icon
93
Lamar Advertising Co
LAMR
$16.7B
$701K 0.03%
14,900
UN
94
DELISTED
Unilever NV New York Registry Shares
UN
$690K 0.03%
18,289
+118
+0.6% +$4.67K
RPV icon
95
Invesco S&P 500 Pure Value ETF
RPV
$1.66B
$683K 0.03%
15,600
CL icon
96
Colgate-Palmolive
CL
$74.8B
$668K 0.03%
11,272
-232
-2% -$13.7K
EPC icon
97
Edgewell Personal Care
EPC
$1.3B
$637K 0.02%
9,431
-12
-0.1% -$887
T icon
98
AT&T
T
$164B
$631K 0.02%
24,695
+1,121
+5% +$29.4K
ORCL icon
99
Oracle
ORCL
$339B
$630K 0.02%
18,990
-15
-0.1% -$487
LUX
100
DELISTED
Luxottica Group
LUX
$615K 0.02%
11,700

Similar funds

Greenleaf Trust's Q3 2013 Portfolio in Review

As of Q3 2013, Greenleaf Trust held 167 positions worth $2.66B, up 4.4% from $2.55B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Greenleaf Trust's Q3 2013 filing shows 3 new, 48 increased, 73 reduced and 7 closed positions. Its largest new stake was Franklin Resources: 187,316 shares worth $9.47M. The largest sale was Stryker, an estimated $60.5M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 82% a quarter earlier, followed by Technology and Financials.

  • Greenleaf Trust's largest Q3 2013 buy was Franklin Resources: 187,316 shares worth $9.47M.
  • Greenleaf Trust added most to Vanguard FTSE Emerging Markets ETF in Q3 2013, an estimated $22.4M increase.
  • Greenleaf Trust's biggest Q3 2013 reduction was Stryker, cutting an estimated $60.5M.
  • Greenleaf Trust fully exited Perrigo in Q3 2013, selling an estimated $644K.
  • Greenleaf Trust's ten largest holdings make up 85% of its $2.66B portfolio in Q3 2013.
  • Greenleaf Trust opened 3 new positions and closed 7 in Q3 2013.
  • Greenleaf Trust's portfolio value rose 4.4% quarter-over-quarter to $2.66B.

Based on Greenleaf Trust's 13F filing for Q3 2013, filed 30 Oct 2013.